Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

McGill University

$25,000.00

Development of novel devices for assessing drugs promoting neuronal regeneration

FY 2018-19

Summary
Ananda Devices is a Montreal based SME dedicated to the development and manufacturing of*microfluidic/organ-on-a-chip devices to increase reproducibility and efficiency of cellular assays. Ananda*Devices' proprietary Neuro-MFD offers a more efficient model to test drugs targeting neurodegenerative*diseases in vitro.*Current generation of Neuro-MFD can only test one drug per experiment and larger labs and the*biopharmaceutical industry need to test thousands of drugs. Ananda Devices aims to develop a novel device*(i.e., HT-Neuro-MFD) that can be adapted to automate the drug testing process.*Partnering with Dr. David Juncker to scale the current advantages of the Neuro-MFD to an HT-Neuro-MFD,*Ananda Devices will benefit from scientific, engineering and technical expertise and tools to develop an*innovative product to respond to the market's demand to accelerate drug discovery in neurological diseases.*The activities detailed in this Project will benefit Canada in a variety of ways:*-Technology: The proposed innovative research will train personnel in the areas of bioengineering,*neuroscience, and microfluidic devices to ensure that Canada remains a leader in these cutting-edge fields.*-Export: Over 80% of Ananda Devices's revenue results from export sales, thereby putting Canada at the*forefront of these innovations has the potential to benefit all Canadians economically and advance the output of*Canadian intellectual property.*-Health: The research will ultimately contribute to the development of new drugs that treat neurodegenerative*diseases, such as Parkinson, Alzheimer's, Multiple Sclerosis and ALS.
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
528835-2018
Name nom
Juncker, David
Department département
Biomedical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Development of novel devices for assessing drugs promoting neuronal regeneration
Keyword
NSERC
Application summary
Ananda Devices is a Montreal based SME dedicated to the development and manufacturing of*microfluidic/organ-on-a-chip devices to increase reproducibility and efficiency of cellular assays. Ananda*Devices' proprietary Neuro-MFD offers a more efficient model to test drugs targeting neurodegenerative*diseases in vitro.*Current generation of Neuro-MFD can only test one drug per experiment and larger labs and the*biopharmaceutical industry need to test thousands of drugs. Ananda Devices aims to develop a novel device*(i.e., HT-Neuro-MFD) that can be adapted to automate the drug testing process.*Partnering with Dr. David Juncker to scale the current advantages of the Neuro-MFD to an HT-Neuro-MFD,*Ananda Devices will benefit from scientific, engineering and technical expertise and tools to develop an*innovative product to respond to the market's demand to accelerate drug discovery in neurological diseases.*The activities detailed in this Project will benefit Canada in a variety of ways:*-Technology: The proposed innovative research will train personnel in the areas of bioengineering,*neuroscience, and microfluidic devices to ensure that Canada remains a leader in these cutting-edge fields.*-Export: Over 80% of Ananda Devices's revenue results from export sales, thereby putting Canada at the*forefront of these innovations has the potential to benefit all Canadians economically and advance the output of*Canadian intellectual property.*-Health: The research will ultimately contribute to the development of new drugs that treat neurodegenerative*diseases, such as Parkinson, Alzheimer's, Multiple Sclerosis and ALS.